NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered MOTS-c from Qing Li Peptide? Mail in a sample (US only) and let us test it.

Test my supply
+16 more ↓
35%
Finnrick rating
#11 of 22 MOTS-c vendors
2 of 6 classifiable tests passed
customers 4.9★ (5)
methodology · Purity focus
Finnrick analysis · MOTS-c

Qing Li Peptide's purity-focus record is strongest in GHK-Cu, Tirzepatide, and Retatrutide, where recent results often recover from earlier purity or fill misses. The catalog is dispersed rather than steady: BPC-157, Tesamorelin, and TB-500 show repeated low-purity, fill, or identity failures, while broad recent volume helps but batch-ID gaps keep some doubt

methodology →
vendor intelligence report
Vendor Intelligence Report: Qing Li Peptide

Domain records, Wayback captures and supplier profiles point away from the Hong Kong-facing history Qing Li presents. The report maps cloned storefronts, exposed staff records and a Pioneer Peptide fee pattern seen in buyer reports.

33 pages6 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.05
86%
38
2
Tirzepatide
$0.50
81%
46
3
Retatrutide
$0.97
80%
131
4
Ipamorelin
$0.60
71%
17
5
PT-141
-
69%
7
6
Semaglutide
$1.20
67%
3
7
Melanotan II
$0.40
66%
7
8
Cagrilintide
$1.80
54%
4
9
Sermorelin
$5.00
50%
6
10
Survodutide
$3.00
48%
3
11
BPC-157
$0.70
43%
36
12
Tesamorelin
$1.80
38%
25
13
CJC-1295
$1.40
35%
19
14
MOTS-cselected
$0.45
35%
6
15
TB-500
$1.20
27%
20
16
Epithalon
$0.50
-
0
17
GLOW
-
-
0
18
HGH
-
-
0
19
KLOW
$0.21
-
0
20
KPV
-
-
0
21
NAD+
$0.02
-
0
22
Pinealon
$0.45
-
0
23
SS-31
$0.44
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%2 Mar 2026: 68%28 Apr 2026: 39%2 Jun 2026: 42%17 Jul 2026: 29%4 Aug 2026: 27%25 Sep 2026: 31%29 Oct 2026: current 35%68%42%35%Mar 26Oct 26
Showing MOTS-c tests only
Qing Li Peptide MOTS-c test history
COA-backed lab tests

About Qing Li Peptide test results from Finnrick

Qing Li Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 15 peptides and 368 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Qing Li Peptide peptides in this dataset are BPC-157 (36 tests), Cagrilintide (4 tests) and CJC-1295 (19 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests. It also includes 1 correction related to this vendor.

Corrections
2026-03-04
Customer update
Sample potency on sample fz959qa was incorrectly captured as 0.10 mg, correct quantity was 10 mg.
Peptide testing

Ordered MOTS-c from Qing Li Peptide? Mail in a sample (US only) and let us test it.

Test my supply